Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromfenac, fluorometholone, and dexamethasone after phacoemulsification
ChiCTR-TRC-12002600Phase 4Completed
- Sponsor
- Zhejiang University
- Start
- Sep 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bromfenac sodium, fluorometholone and dexamethasone in Postoperative ocular inflammation and cystoid macular edema (CME) (4 arms), sponsored by Zhejiang University. Primary endpoints: photon count value, retinal foveal thickness and 1 more. Started Sep 2014; status: completed.
02
Drugs
bromfenac sodiumfluorometholonedexamethasone
03
Conditions
Postoperative ocular inflammationcystoid macular edema (CME)
Beyond the preview
Go deeper on ChiCTR-TRC-12002600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002600.